FEATURED
Technow Plans Biologics as BIOVECTRA Pillar
As Charlottetown-based drug manufacturer BIOVECTRA launches its new, $90 million biomanufacturing facility, CEO Oliver Technow says expansion of its production capacity
recent news
CVCA Finds Weak VC Investing in Q1
Atlantic Canada suffered a weak first quarter for venture capital investment, says the country’s main private capital association, highlighting weak investment across
Myomar Molecular Closes $3.5M Round
Halifax-based Myomar Molecular, which has developed a urine test that assesses muscle health, has closed a $3.5 million seed round that will help it expand into the U.S.
Novonix Spins Off Two Halifax Companies
Dr. Chris Burns, the former CEO of Novonix Battery Technology Solutions, has taken the battery innovator’s Halifax operations private, setting up two new companies, each